| Trial ID: | L0622 |
| Source ID: | NCT00745914
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Endstage Renal Disease|Diabetes
|
| Interventions: |
DRUG: Pioglitazone|DRUG: Placebo comparator
|
| Outcome Measures: |
Primary: Change in carotid plaque volume, 12 months | Secondary: Change in inflammatory markers include C-reactive protein, interleukin-6, adiponectin, metalloproteinases, 12 months
|
| Sponsor/Collaborators: |
Sponsor: The University of Hong Kong
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-09
|
| Completion Date: |
2013-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-10
|
| Locations: |
Queen Mary Hospital and Tung Wah Hospital, Hong Kong, 0000, Hong Kong|Queen Mary Hospital, Tung Wah Hospital, Hong Kong, 0000, Hong Kong
|
| URL: |
https://clinicaltrials.gov/show/NCT00745914
|
